RELAPSE MULTIPLE MYELOMA
Clinical trials for RELAPSE MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSE MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial offers hope for patients out of options
Disease control Not yet recruitingThis is an early-stage study testing the safety of a new type of treatment called FT836 CAR T-cell therapy, given alongside an existing drug called daratumumab. It is for adults with advanced multiple myeloma that has come back or stopped responding to at least three prior treatm…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Scientists test Double-Punch cancer vaccine to boost CAR-T power
Disease control Not yet recruitingThis early-phase study is testing whether adding a personalized cancer vaccine can make a powerful cell therapy (CAR-T) work better for people with multiple myeloma that has come back or stopped responding to other treatments. The vaccine is made from a patient's own immune cells…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: David Avigan • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug cocktail aims to tame Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study is testing a combination of four medications for people with multiple myeloma that has returned or stopped responding to prior treatments. The main goal is to find a safe and effective dose for the drug combination. Researchers will enroll about 62 adults to see if thi…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Natalie Callander • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC